Filing Details

Accession Number:
0000921895-20-003084
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-20 19:46:10
Reporting Period:
2020-11-18
Accepted Time:
2020-11-20 19:46:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Plx Pharma Inc. PLXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1319551 J Michael Valentino 9 Fishers Lane
Suite E
Sparta NJ 07871
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-18 264,900 $3.79 461,690 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2020-11-18 160,000 $0.00 160,000 $5.15
Common Stock Warrants (right to buy) Acquisiton 2020-11-18 291,390 $0.00 291,390 $4.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
160,000 2030-11-18 No 4 A Direct
291,390 2020-11-18 2025-11-18 No 4 P Direct
Footnotes
  1. Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
  2. These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.
  3. Issued pursuant to a private placement in connection with the purchase of immediately serparable units comprised of common stock and warrants.